Global Therapeutic Respiratory Devices Market

Global Therapeutic Respiratory Devices Market Size, Share, Growth Analysis, By Product(Nebulizer, Humidifiers), By Technology(Electrostatic Filtration, HEPA Filter Technology), By End Use(Hospital, Homecare Settings), By Application(COPD, Obstructive Sleep Apnea), By Filters(Nebulizer filters, Humidifier Filters) - Industry Forecast 2024-2031

Report ID: SQMIG35A2647 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 155 | Figures: 78

Global Therapeutic Respiratory Devices Market Competitive Landscape

The market is fragmented with presence of key players who employ various growth strategies including mergers and acquisitions, collaborations, product releases, and partnership with local players to maintain dominance. Some of the key players include BD, General Electric Company, Chart Industries, Koninklijke Philips N.V, Compumedics Limited, ICU Medical, Inc. and Invacare Corporation. Innovation and development of new products is the key strategies of these major players to increase the consumer base.

Therapeutic Respiratory Devices Market Key Player’s Company Profiles

  • Inogen, Inc.
  • GlaxoSmithKline plc
  • Novartis International AG
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • Philips Healthcare
  • ResMed Inc.
  • Medtronic plc
  • Smiths Medical
  • Masimo Corporation
  • Fisher & Paykel Healthcare Corporation Limited
  • Drägerwerk AG & Co. KGaA
  • Hamilton Medical AG
  • Vyaire Medical Inc.
  • Invacare Corporation
  • DeVilbiss Healthcare LLC
  • Drive DeVilbiss Healthcare
  • Chart Industries Inc.
  • Teleflex Incorporated
  • Koninklijke Philips N.V.

Therapeutic Respiratory Devices Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Therapeutic Respiratory Devices Market size was valued at USD 47 billion in 2019 and is poised to grow from USD 48.88 billion in 2023 to USD 64.5 billion by 2031, growing at a CAGR of 4% in the forecast period (2024-2031).

The market is fragmented with presence of key players who employ various growth strategies including mergers and acquisitions, collaborations, product releases, and partnership with local players to maintain dominance. Some of the key players include BD, General Electric Company, Chart Industries, Koninklijke Philips N.V, Compumedics Limited, ICU Medical, Inc. and Invacare Corporation. Innovation and development of new products is the key strategies of these major players to increase the consumer base. 'Inogen, Inc.', 'GlaxoSmithKline plc', 'Novartis International AG', 'AstraZeneca plc', 'Boehringer Ingelheim GmbH', 'Philips Healthcare', 'ResMed Inc.', 'Medtronic plc', 'Smiths Medical', 'Masimo Corporation', 'Fisher & Paykel Healthcare Corporation Limited', 'Drägerwerk AG & Co. KGaA', 'Hamilton Medical AG', 'Vyaire Medical Inc.', 'Invacare Corporation', 'DeVilbiss Healthcare LLC', 'Drive DeVilbiss Healthcare', 'Chart Industries Inc.', 'Teleflex Incorporated', 'Koninklijke Philips N.V.'

The demand for therapeutic respiratory devices is driven by the increase in respiratory conditions such asthma and chronic obstructive pulmonary disease.

In the therapeutic respiratory device market, intelligent ventilators, portable PAP machines, smart inhalers, and nebulizers are all growing in popularity and assisting in giving clinicians real-time monitoring and data transfer. The market for therapeutic respiratory devices is anticipated to grow quickly during the forecast period due to the high prevalence of respiratory illnesses in India, Brazil, China, and Japan.

North America dominated the global market in 2021.This can be attributed to a sizable elderly population as well as the increased prevalence of chronic respiratory illnesses. Additionally, the major share of the North American market is due to the availability of reimbursement in the U.S. healthcare centres accounts, growing public awareness of healthcare issues, improved healthcare infrastructure, an increase in the number of outpatient surgeries, and economic growth that is aided by expanding insurance coverage. According to the United States Death Statistics, in 2021 respiratory disorders claimed the lives of 44,630 people. The market for therapeutic respiratory devices is also anticipated to grow in the next years as a result of rising healthcare costs and an increase in respiratory illnesses in the United States.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Therapeutic Respiratory Devices Market

Report ID: UCMIG35A2870 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Blood Transfusion Devices Market
Buy Now GET FREE SAMPLE
Global Therapeutic Respiratory Devices Market

Report ID: SQMIG35A2748 | Region: Global | Published Date: February, 2024 | Pages: 219 | Tables: 91 | Figures: 67

Global Endoscopic Retrograde Cholangiopancreatography Market
Buy Now GET FREE SAMPLE
Global Therapeutic Respiratory Devices Market

Report ID: SQMIG35A2561 | Region: Global | Published Date: February, 2024 | Pages: 219 | Tables: 118 | Figures: 72

Global Specimen Retrieval Market
Buy Now GET FREE SAMPLE
Global Therapeutic Respiratory Devices Market

Report ID: UCMIG35A2875 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Automated Analyzers Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Therapeutic Respiratory Devices Market

Product ID: SQMIG35A2647

$5,300
BUY NOW GET FREE SAMPLE